Literature DB >> 1737000

Binding of protein synthesis initiation factor 4E to oligoribonucleotides: effects of cap accessibility and secondary structure.

S E Carberry1, D E Friedland, R E Rhoads, D J Goss.   

Abstract

The binding of rabbit globin mRNA to the 25-kDa cap binding protein eIF-4E from human erythrocytes was found to be 5.3-fold stronger than the binding of the cap analogue m7GpppG to eIF-4E [Gross et al. (1990) Biochemistry 29, 5008-5012]. In order to investigate whether this effect is due to the longer sequence of nucleotides in globin mRNA or to other features such as cap accessibility or secondary structure, oligoribonucleotide analogues of rabbit alpha-globin mRNA were synthesized by T7 RNA polymerase from a synthetic oligodeoxynucleotide template in the presence of m7GpppG; these oligoribonucleotide analogues possess varying degrees of cap accessibility and secondary structure. Equilibrium association constants for the interaction of these oligoribonucleotides and purified human erythrocyte eIF-4E were obtained from direct fluorescence titration experiments. The data indicate that while the presence of the m7G cap is required for efficient recognition by eIF-4E, the cap need not be completely sterically accessible, since other structural features within the mRNA also influence binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737000     DOI: 10.1021/bi00120a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Eukaryotic translation initiation factor 4E-dependent translation is not essential for survival of starved yeast cells.

Authors:  I Paz; M Choder
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

2.  The structure of eukaryotic translation initiation factor-4E from wheat reveals a novel disulfide bond.

Authors:  Arthur F Monzingo; Simrit Dhaliwal; Anirvan Dutt-Chaudhuri; Angeline Lyon; Jennifer H Sadow; David W Hoffman; Jon D Robertus; Karen S Browning
Journal:  Plant Physiol       Date:  2007-02-23       Impact factor: 8.340

3.  Identification of the cap binding domain of human recombinant eukaryotic protein synthesis initiation factor 4E using a photoaffinity analogue.

Authors:  D E Friedland; M T Shoemaker; Y Xie; Y Wang; C H Hagedorn; D J Goss
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

4.  Synthesis of a fluorescent 7-methylguanosine analog and a fluorescence spectroscopic study of its reaction with wheatgerm cap binding proteins.

Authors:  J Ren; D J Goss
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

5.  Novel "anti-reverse" cap analogs with superior translational properties.

Authors:  Jacek Jemielity; Tolvert Fowler; Joanna Zuberek; Janusz Stepinski; Magdalena Lewdorowicz; Anna Niedzwiecka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

6.  Dynamic recognition of the mRNA cap by Saccharomyces cerevisiae eIF4E.

Authors:  Seán E O'Leary; Alexey Petrov; Jin Chen; Joseph D Puglisi
Journal:  Structure       Date:  2013-10-31       Impact factor: 5.006

7.  Heterogeneous Dynamics of Protein-RNA Interactions across Transcriptome-Derived Messenger RNA Populations.

Authors:  Burak Çetin; Gary J Song; Seán E O'Leary
Journal:  J Am Chem Soc       Date:  2020-12-14       Impact factor: 15.419

Review 8.  Quantitative studies of mRNA recruitment to the eukaryotic ribosome.

Authors:  Christopher S Fraser
Journal:  Biochimie       Date:  2015-03-02       Impact factor: 4.372

9.  Simulation of non-specific protein-mRNA interactions.

Authors:  James Magee; Jim Warwicker
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

10.  Cap-proximal nucleotides via differential eIF4E binding and alternative promoter usage mediate translational response to energy stress.

Authors:  Ana Tamarkin-Ben-Harush; Jean-Jacques Vasseur; Françoise Debart; Igor Ulitsky; Rivka Dikstein
Journal:  Elife       Date:  2017-02-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.